October 31, 2022
Taichi Kido, Director, Deloitte Tohmatsu Consulting (left) Deloitte Tohmatsu Consulting proposed three drug pricing schemes designed to trigger the consolidation of generic makers on October 27, offering them as a springboard for expert discussions to address the quality, supply, and...read more